Get the app
US › Financial Services

Helius Medical Technologies Inc Class A (HSDT)

US · Financial Services · Asset Management

$1.930.00%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$2.5M
Revenue YoY
+5774.4%
Net profit
$-30.3M
EPS
$-0.05
EPS estimate
$-0.02
Net margin
-1,197.8%

EPS came in at -0.05 against a street estimate of -0.02 — a miss of 150.0%.

Key statistics

Market cap
$147.1M
P/E
0.0
Forward P/E
0.0
P/B
0.87
Book value
$2.81
EPS (TTM)
$53.74
52-week high
$5.99
52-week low
$1.19
50-day MA
$2.40
200-day MA
$2.11
Beta
1.12

Analyst view

Analysts rate Helius Medical Technologies Inc Class A a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.50.

Shareholding

Insiders
16.20%
Institutions
25.55%

Largest institutional holders

FundStake
Pantera Capital Partners LP11.40%
Kathmere Capital Management, LLC10.50%
Arrington Capital Management, LLC1.51%
BlackRock Inc1.45%
VR Advisory Services Ltd1.33%
LPL Financial Corp1.28%
Vanguard Capital Management, LLC1.27%
Geode Capital Management, LLC1.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Helius Medical Technologies Inc Class A — free to start.

Open in the appGoogle PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyRoyal Bank of CanadaWells Fargo & CompanyGoldman Sachs Group IncMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-11-07.